1. Home
  2. ANGO vs HPF Comparison

ANGO vs HPF Comparison

Compare ANGO & HPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGO
  • HPF
  • Stock Information
  • Founded
  • ANGO 1988
  • HPF 2002
  • Country
  • ANGO United States
  • HPF United States
  • Employees
  • ANGO N/A
  • HPF N/A
  • Industry
  • ANGO Medical/Dental Instruments
  • HPF Finance Companies
  • Sector
  • ANGO Health Care
  • HPF Finance
  • Exchange
  • ANGO Nasdaq
  • HPF Nasdaq
  • Market Cap
  • ANGO 400.8M
  • HPF 359.7M
  • IPO Year
  • ANGO 2004
  • HPF N/A
  • Fundamental
  • Price
  • ANGO $11.73
  • HPF $16.68
  • Analyst Decision
  • ANGO Strong Buy
  • HPF
  • Analyst Count
  • ANGO 3
  • HPF 0
  • Target Price
  • ANGO $19.33
  • HPF N/A
  • AVG Volume (30 Days)
  • ANGO 442.6K
  • HPF 35.3K
  • Earning Date
  • ANGO 10-02-2025
  • HPF 01-01-0001
  • Dividend Yield
  • ANGO N/A
  • HPF 8.96%
  • EPS Growth
  • ANGO N/A
  • HPF N/A
  • EPS
  • ANGO N/A
  • HPF N/A
  • Revenue
  • ANGO $300,718,000.00
  • HPF N/A
  • Revenue This Year
  • ANGO $8.18
  • HPF N/A
  • Revenue Next Year
  • ANGO $5.15
  • HPF N/A
  • P/E Ratio
  • ANGO N/A
  • HPF N/A
  • Revenue Growth
  • ANGO 2.73
  • HPF N/A
  • 52 Week Low
  • ANGO $6.63
  • HPF $12.99
  • 52 Week High
  • ANGO $13.50
  • HPF $16.80
  • Technical
  • Relative Strength Index (RSI)
  • ANGO 51.33
  • HPF 50.53
  • Support Level
  • ANGO $11.53
  • HPF $16.56
  • Resistance Level
  • ANGO $12.18
  • HPF $16.75
  • Average True Range (ATR)
  • ANGO 0.35
  • HPF 0.13
  • MACD
  • ANGO -0.09
  • HPF -0.01
  • Stochastic Oscillator
  • ANGO 23.57
  • HPF 42.05

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

About HPF John Hancock Pfd Income Fund II Pfd Income Fund II

John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.

Share on Social Networks: